Mechanism of amino acid-induced skeletal muscle insulin resistance in humans.

Plasma concentrations of amino acids are frequently elevated in insulin-resistant states, and a protein-enriched diet can impair glucose metabolism. This study examined effects of short-term plasma amino acid (AA) elevation on whole-body glucose disposal and cellular insulin action in skeletal muscle. Seven healthy men were studied for 5.5 h during euglycemic (5.5 mmol/l), hyperinsulinemic (430 pmol/l), fasting glucagon (65 ng/l), and growth hormone (0.4 microg/l) somatostatin clamp tests in the presence of low (approximately 1.6 mmol/l) and increased (approximately 4.6 mmol/l) plasma AA concentrations. Glucose turnover was measured with D-[6,6-(2)H(2)]glucose. Intramuscular concentrations of glycogen and glucose-6-phosphate (G6P) were monitored using (13)C and (31)P nuclear magnetic resonance spectroscopy, respectively. A approximately 2.1-fold elevation of plasma AAs reduced whole-body glucose disposal by 25% (P < 0.01). Rates of muscle glycogen synthesis decreased by 64% (180--315 min, 24 plus minus 3; control, 67 plus minus 10 micromol center dot l(-1) center dot min(-1); P < 0.01), which was accompanied by a reduction in G6P starting at 130 min (DeltaG6P(260--300 min), 18 plus minus 19; control, 103 plus minus 33 micromol/l; P < 0.05). In conclusion, plasma amino acid elevation induces skeletal muscle insulin resistance in humans by inhibition of glucose transport/phosphorylation, resulting in marked reduction of glycogen synthesis.

[1]  A. Vaag,et al.  Effect of hyperglycemia per se on glucose turnover rates in patients with insulin-dependent diabetes. , 1993, Metabolism: clinical and experimental.

[2]  G. Shulman,et al.  Applications of NMR spectroscopy to study muscle glycogen metabolism in man. , 1999, Annual review of medicine.

[3]  N. Abumrad,et al.  alpha-Ketoisocaproate is superior to leucine in sparing glucose utilization in humans. , 1986, The American journal of physiology.

[4]  S. Fajans,et al.  Stimulation of insulin secretion by amino acids. , 1966, The Journal of clinical investigation.

[5]  M. Patti.  Nutrient Modulation of Cellular Insulin Action , 1999, Annals of the New York Academy of Sciences.

[6]  P. Felig,et al.  Plasma amino acid levels and insulin secretion in obesity. , 1970, The New England journal of medicine.

[7]  J. Livingston,et al.  Regulation of rat glucagon receptor expression. , 1994, Biochemical and biophysical research communications.

[8]  P. Flakoll,et al.  Short-term regulation of insulin-mediated glucose utilization in four-day fasted human volunteers: role of amino acid availability , 1992, Diabetologia.

[9]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[10]  R. Geyer,et al.  Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.

[11]  L. Tappy,et al.  Effects of Amino Acids on Glucose Disposal , 1990, Diabetes.

[12]  G. Shulman,et al.  Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. , 1998, The New England journal of medicine.

[13]  Andrée Tixier-Vidal,et al.  The anterior pituitary , 1975 .

[14]  M. Buse,et al.  Oxidation of branched chain amino acids by isolated hearts and diaphragms of the rat. The effect of fatty acids, glucose, and pyruvate respiration. , 1972, The Journal of biological chemistry.

[15]  J. Olefsky,et al.  Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. , 2001, Diabetes.

[16]  D. Mercer,et al.  Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. , 1973, The Journal of clinical investigation.

[17]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[18]  M. Sanders,et al.  Glutamine is a powerful effector of heat shock protein expression in Drosophila Kc cells , 1991, Journal of cellular physiology.

[19]  A. Jost.  [The anterior pituitary of the fetus]. , 1962, Biologie medicale.

[20]  P. Pisters,et al.  The effects of euglycemic hyperinsulinemia and amino acid infusion on regional and whole body glucose disposal in man. , 1991, Metabolism: clinical and experimental.

[21]  M. Roden,et al.  Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  P. Scifo,et al.  Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. , 2001, The Journal of clinical endocrinology and metabolism.

[23]  E. Roth,et al.  Postoperative glycyl-glutamine infusion reduces immunosuppression: partial prevention of the surgery induced decrease in HLA-DR expression on monocytes. , 2001, Clinical nutrition.

[24]  A. Schiffrin,et al.  Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. , 1994, Metabolism: clinical and experimental.

[25]  E Moser,et al.  Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. , 1999, Diabetes.

[26]  S. Adibi.  Metabolism of branched-chain amino acids in altered nutrition. , 1976, Metabolism: clinical and experimental.

[27]  M. Haymond,et al.  Decreased Uptake of Glucose by Human Forearm During Infusion of Leucine, Isoleucine, or Threonine , 1987, Diabetes.

[28]  P. Felig.  Amino acid metabolism in man. , 1975, Annual review of biochemistry.

[29]  R. DeFronzo,et al.  Effect of dietary protein on in vivo insulin action and liver glycogen repletion. , 1989, The American journal of physiology.

[30]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[31]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[32]  E. Jéquier,et al.  Effects of infused amino acids on glucose production and utilization in healthy human subjects. , 1992, The American journal of physiology.

[33]  S. Marshall,et al.  Role of amino acids in modulating glucose-induced desensitization of the glucose transport system. , 1989, The Journal of biological chemistry.

[34]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[35]  A. Goldberg,et al.  Leucine inhibits oxidation of glucose and pyruvate in skeletal muscles during fasting. , 1978, The Journal of biological chemistry.

[36]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[37]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[38]  R. Shulman,et al.  In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Frame.  The levels of individual free amino acids in the plasma of normal man at various intervals after a high-protein meal. , 1958, The Journal of clinical investigation.

[40]  D. Grönemeyer,et al.  Effect of long-term dietary protein intake on glucose metabolism in humans , 2000, Diabetologia.

[41]  J. Williamson,et al.  Effects of branched chain alpha-ketoacids on the metabolism of isolated rat liver cells. III. Interactions with pyruvate dehydrogenase. , 1980, The Journal of biological chemistry.

[42]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[43]  P. Felig,et al.  Splanchnic glucose and amino acid metabolism in obesity. , 1974, The Journal of clinical investigation.

[44]  J. Miles,et al.  Effects of pulsatile delivery of basal growth hormone on lipolysis in humans. , 1996, The American journal of physiology.

[45]  K. Petersen,et al.  13C/31P NMR studies on the mechanism of insulin resistance in obesity. , 1998, Diabetes.

[46]  W. Waldhäusl,et al.  Combined 17 alpha- and 18-hydroxylase deficiency associated with complete male pseudohermaphroditism and hypoaldosteronism. , 1978, The Journal of clinical endocrinology and metabolism.

[47]  C. Kahn,et al.  Bidirectional modulation of insulin action by amino acids. , 1998, The Journal of clinical investigation.

[48]  N. Musso,et al.  Reversed-phase HPLC separation of plasma norepinephrine, epinephrine, and dopamine, with three-electrode coulometric detection. , 1989, Clinical chemistry.

[49]  E. Barrett,et al.  Growth Hormone Stimulates Skeletal Muscle Protein Synthesis and Antagonizes Insulin's Antiproteolytic Action in Humans , 1992, Diabetes.

[50]  R. Unger,et al.  Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. , 1968, The Journal of clinical investigation.

[51]  R. Shulman,et al.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.